Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients—COVIDOUT study

Detalles Bibliográficos
Autores principales: Schönlein, Martin, Wrage, Victoria, Ghandili, Susanne, Mellinghoff, Sibylle C., Brehm, Thomas Theo, Leypoldt, Lisa B., Utz, Nils, Schrader, Roland M., Alsdorf, Winfried, Börschel, Niklas, Bußmann, Lara, Schönrock, Martin, Perlick, Dorothea, Schön, Gerhard, Verpoort, Karl, Lütgehetmann, Marc, Schulze zur Wiesch, Julian, Weisel, Katja C., Bokemeyer, Carsten, Schafhausen, Philippe, Sinn, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040439/
https://www.ncbi.nlm.nih.gov/pubmed/35512712
http://dx.doi.org/10.1016/j.ccell.2022.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040439/
https://www.ncbi.nlm.nih.gov/pubmed/35512712
http://dx.doi.org/10.1016/j.ccell.2022.04.016

Ejemplares similares